Andrei Sorin Bolocan, PhD

Research scientist currently working at 4D Pharma PLC (Aberdeen, UK) a company focused on the development of live biotherapeutic products (LBPs) for the human gut microbiome. LPBs represent a class of drugs that contain live organisms for the prevention, treatment or cure of diseases such as inflammatory bowel syndrome, inflammatory bowel disease (IBD), asthma, cancer and Parkinsons.

PhageUGAL Summer School: Infecting Romanian research with phage This week, Colin Buttimer and colleagues from APC Microbiome in Ireland and the University of Galati in Romania share their inspiring experience organizing and teaching Romania's first phage summer school. Because of their success, a food… 42.Aug 29, 2019Colin Buttimer, Andrei Sorin Bolocan, Anca Ioana Nicolau, Joan Colom Comas, Leontina Grigore-Gurgu